Group 1 - MSCI China Index has added 14 new stocks including Horizon Robotics, Laopu Gold, and Sanofi Pasteur, while 19 Hong Kong stocks including Yaoshi Bang and Maifushi have been included in the MSCI China Small Cap Index, effective after market close on August 26 [1] - The MSCI China Small Cap Index tracks the performance of small-cap stocks in China and provides investors with a tool to invest in high-growth small and medium-sized enterprises, which typically have higher growth potential but lower market capitalization and liquidity [1] - The index is known for its strict selection criteria and frequent adjustments, making it a reference for many international investment institutions, with index funds and passive funds likely to see increased inflows following the inclusion of new stocks [1] Group 2 - Yaoshi Bang's inclusion in the MSCI China Small Cap Index is a recognition of the company's operational performance and growth potential, which will help broaden its investor base and enhance liquidity [2] - The company expects a net profit of no less than RMB 70 million for the first half of the year, more than 3.2 times that of the same period last year, despite challenges in the pharmaceutical distribution market [2] - Yaoshi Bang has achieved significant coverage, reaching 98.9% of counties and 91.2% of townships in China, with 491,000 pharmacy users and 330,000 grassroots medical institution users, indicating substantial scale effects [2] - The digital pharmaceutical distribution market in China is projected to reach RMB 358.3 billion by 2027, and with the company's focus on private brand business and supply chain optimization, its leading position in the niche market is expected to expand, entering a phase of profit release with significant value potential [2]
药师帮(09885.HK)获纳入MSCI全球小型股指数